Striatal Nurr1, but not FosB Expression links a Levodopa-induced Dyskinesia Phenotype to Genotype in Fisher 344 vs. Lewis Hemiparkinsonian Rats

Numerous genes, and alterations in their expression, have been identified as risk factors for developing levodopa-induced dyskinesia (LID). However, our understanding of the complexities of molecular changes remains insufficient for development of clinical treatment. In the current study we used gen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Neurol
Autors principals: Steece-Collier, Kathy, Collier, Timothy J., Lipton, Jack W., Stancati, Jennifer A., Winn, Mary E., Cole-Strauss, Allyson, Sellnow, Rhyomi, Conti, Melissa M., Mercado, Natosha M., Nillni, Eduardo A., Sortwell, Caryl E., Manfredsson, Fredric P., Bishop, Christopher
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7365252/
https://ncbi.nlm.nih.gov/pubmed/32387398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2020.113327
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars